DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,058 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,873,807 | +3.7% | 27,512 | +3.7% | 0.11% | +1.9% |
Q1 2024 | $6,628,238 | +10.7% | 26,543 | +2.5% | 0.11% | -8.5% |
Q4 2023 | $5,989,069 | -6.3% | 25,889 | -10.9% | 0.12% | -18.6% |
Q3 2023 | $6,389,016 | -4.4% | 29,052 | +4.3% | 0.14% | -2.0% |
Q2 2023 | $6,683,877 | +6.3% | 27,849 | +11.6% | 0.15% | -2.0% |
Q1 2023 | $6,290,272 | -0.9% | 24,957 | +4.0% | 0.15% | -13.2% |
Q4 2022 | $6,344,969 | +1.9% | 23,999 | -0.5% | 0.17% | -26.6% |
Q3 2022 | $6,227,000 | -15.5% | 24,109 | -17.1% | 0.24% | -6.0% |
Q2 2022 | $7,372,000 | +24.8% | 29,079 | +44.3% | 0.25% | +8.6% |
Q1 2022 | $5,909,000 | -13.9% | 20,145 | -3.4% | 0.23% | -16.8% |
Q4 2021 | $6,862,000 | +12.1% | 20,857 | +3.7% | 0.28% | -1.1% |
Q3 2021 | $6,123,000 | +17.7% | 20,112 | +3.7% | 0.28% | +17.5% |
Q2 2021 | $5,204,000 | +43.3% | 19,392 | +20.2% | 0.24% | +25.0% |
Q1 2021 | $3,631,000 | +8.5% | 16,132 | +7.1% | 0.19% | -20.0% |
Q4 2020 | $3,346,000 | +11.6% | 15,063 | +8.2% | 0.24% | -8.0% |
Q3 2020 | $2,998,000 | +11.2% | 13,923 | -8.6% | 0.26% | +2.0% |
Q2 2020 | $2,695,000 | +35.6% | 15,241 | +6.2% | 0.26% | +23.7% |
Q1 2020 | $1,987,000 | +4.4% | 14,356 | +15.8% | 0.21% | +29.4% |
Q4 2019 | $1,903,000 | +8.6% | 12,399 | +2.2% | 0.16% | -2.4% |
Q3 2019 | $1,752,000 | +2.8% | 12,130 | +1.7% | 0.16% | -2.4% |
Q2 2019 | $1,704,000 | +681.7% | 11,923 | +494.1% | 0.17% | +663.6% |
Q3 2018 | $218,000 | -76.2% | 2,007 | -97.0% | 0.02% | -78.0% |
Q2 2018 | $917,000 | +45.8% | 67,022 | +944.0% | 0.10% | +19.0% |
Q1 2018 | $629,000 | -24.5% | 6,420 | -28.5% | 0.08% | -33.3% |
Q4 2017 | $833,000 | +5.8% | 8,976 | -2.2% | 0.13% | +3.3% |
Q3 2017 | $787,000 | -58.7% | 9,176 | -59.4% | 0.12% | -60.8% |
Q2 2017 | $1,907,000 | +39.2% | 22,600 | +66.7% | 0.31% | +3.7% |
Q2 2016 | $1,370,000 | +27.6% | 13,560 | +19.8% | 0.30% | +25.5% |
Q1 2016 | $1,074,000 | +105.0% | 11,323 | +84.0% | 0.24% | +63.7% |
Q3 2015 | $524,000 | +60.7% | 6,153 | +61.7% | 0.15% | +47.5% |
Q2 2015 | $326,000 | -58.6% | 3,805 | -64.2% | 0.10% | -70.7% |
Q1 2015 | $788,000 | +14.2% | 10,635 | +4.0% | 0.34% | +1.8% |
Q4 2014 | $690,000 | +148.2% | 10,225 | +179.0% | 0.33% | +129.0% |
Q3 2014 | $278,000 | -50.4% | 3,665 | -49.8% | 0.14% | -8.2% |
Q2 2014 | $561,000 | +98.2% | 7,300 | +93.4% | 0.16% | -5.4% |
Q1 2014 | $283,000 | +1.8% | 3,775 | +4.9% | 0.17% | -0.6% |
Q4 2013 | $278,000 | -21.7% | 3,600 | -29.8% | 0.17% | -28.2% |
Q3 2013 | $355,000 | -9.2% | 5,125 | -17.0% | 0.23% | -14.9% |
Q2 2013 | $391,000 | +0.3% | 6,175 | -1.6% | 0.28% | -6.5% |
Q1 2013 | $390,000 | -45.7% | 6,275 | -51.1% | 0.29% | -52.7% |
Q4 2012 | $718,000 | +19.5% | 12,840 | +17.9% | 0.62% | +12.9% |
Q3 2012 | $601,000 | – | 10,890 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |